+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Accelerate Diagnostics Receives Fda Marketing Authorization For The Accelerate Pheno System And Accelerate Phenotest Bc Kit is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Accelerate Diagnostics Receives Fda Marketing Authorization For The Accelerate Pheno System And Accelerate Phenotest Bc Kit | RobinsPost News & Noticias

Accelerate Diagnostics GAAP EPS of -$0.89 misses by $0.27, revenue of $3M misses by $0.45M


Accelerate Diagnostics press release (NASDAQ:AXDX): Q4 GAAP EPS of -$0.89 misses by $0.27. Revenue of $3M misses by $0.45M. Accelerate Diagnostics prices $15M public offering and private placement ... Read More

Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results


President and CEO of Accelerate Diagnostics, Inc. "In addition, we continue to expand and secure our Accelerate Pheno ® customer base, with an upgrade path to Wave adoption. Based on consistent ... Read More

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q4 2023 Earnings Call Transcript


Accelerate Diagnostics, Inc. misses on earnings ... trial and clinical trial followed by an FDA submission and clearance for the Wave system and a full gram-negative positive blood culture menu. Read More

AXDX Stock Earnings: Accelerate Diagnostics Misses EPS, Misses Revenue for Q4 2023


Accelerate Diagnostics (NASDAQ:AXDX) just reported results for the fourth quarter of 2023. Accelerate Diagnostics reported earnings per share of -89 cents. This was below the analyst estimate for ... Read More

Earnings call: Accelerate Diagnostics reports mixed results amid progress


Accelerate Diagnostics is making headway with its Wave system, which is expected to transform automated susceptibility testing. The company anticipates submitting its FDA clearance application for ... Read More

Recap: Accelerate Diagnostics Q4 Earnings


Accelerate Diagnostics AXDX reported its Q4 earnings results on Thursday, March 28, 2024 at 04:05 PM. Here's what investors need to know about the announcement. Accelerate Diagnostics missed ... Read More

A Preview Of Accelerate Diagnostics's Earnings


Accelerate Diagnostics AXDX is set to give its latest quarterly earnings report on Thursday, 2024-03-28. Here's what investors need to know before the announcement. Analysts estimate that ... Read More

Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results


We may use it to: Verify your identity, personalize the content you receive, or create and administer ... Gear advertisements and other marketing efforts towards your interests. Read More

Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results


See accompanying notes to consolidated financial statements. Read More

Accelerate Diagnostics, Inc.: Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results


President and CEO of Accelerate Diagnostics, Inc. "In addition, we continue to expand and secure our Accelerate Pheno ® customer base, with an upgrade path to Wave adoption. Based on consistent ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus